Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

View source ↗

Summary

A prospective study is evaluating whether serum glycomic biomarkers (GLYcomics) can predict graft loss and mortality after liver transplantation; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Ghent | Conditions: Liver Transplant Failure, Prognostic Biomarkers | Status: RECRUITING